tiprankstipranks
Trending News
More News >
Surgery Partners Inc (SGRY)
NASDAQ:SGRY

Surgery Partners (SGRY) Stock Statistics & Valuation Metrics

Compare
380 Followers

Total Valuation

Surgery Partners has a market cap or net worth of $1.65B. The enterprise value is $5.43B.
Market Cap$1.65B
Enterprise Value$5.43B

Share Statistics

Surgery Partners has 129,419,830 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding129,419,830
Owned by Insiders
Owned by Institutions

Financial Efficiency

Surgery Partners’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is 4.24%.
Return on Equity (ROE)-0.05
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)4.24%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee220.58K
Profits Per Employee6.59K
Employee Count15,000
Asset Turnover0.40
Inventory Turnover26.33

Valuation Ratios

The current PE Ratio of Surgery Partners is ―. Surgery Partners’s PEG ratio is 0.47.
PE Ratio
PS Ratio0.59
PB Ratio1.15
Price to Fair Value1.15
Price to FCF10.05
Price to Operating Cash Flow5.91
PEG Ratio0.47

Income Statement

In the last 12 months, Surgery Partners had revenue of 3.31B and earned -77.90M in profits. Earnings per share was -0.61.
Revenue3.31B
Gross Profit765.00M
Operating Income389.50M
Pretax Income116.90M
Net Income-77.90M
EBITDA565.50M
Earnings Per Share (EPS)-0.61

Cash Flow

In the last 12 months, operating cash flow was 274.30M and capital expenditures -78.70M, giving a free cash flow of 195.60M billion.
Operating Cash Flow274.30M
Free Cash Flow195.60M
Free Cash Flow per Share1.51

Dividends & Yields

Surgery Partners pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.19
52-Week Price Change-46.04%
50-Day Moving Average15.00
200-Day Moving Average19.29
Relative Strength Index (RSI)33.43
Average Volume (3m)1.84M

Important Dates

Surgery Partners upcoming earnings date is May 5, 2026, Before Open (Confirmed).
Last Earnings DateMar 2, 2026
Next Earnings DateMay 5, 2026
Ex-Dividend Date

Financial Position

Surgery Partners as a current ratio of 1.87, with Debt / Equity ratio of 234.97%
Current Ratio1.87
Quick Ratio1.71
Debt to Market Cap1.45
Net Debt to EBITDA6.69
Interest Coverage Ratio1.43

Taxes

In the past 12 months, Surgery Partners has paid 18.00M in taxes.
Income Tax18.00M
Effective Tax Rate0.15

Enterprise Valuation

Surgery Partners EV to EBITDA ratio is 10.17, with an EV/FCF ratio of 29.40.
EV to Sales1.74
EV to EBITDA10.17
EV to Free Cash Flow29.40
EV to Operating Cash Flow20.96

Balance Sheet

Surgery Partners has $239.90M in cash and marketable securities with $4.02B in debt, giving a net cash position of -$3.78B billion.
Cash & Marketable Securities$239.90M
Total Debt$4.02B
Net Cash-$3.78B
Net Cash Per Share-$29.25
Tangible Book Value Per Share-$13.43

Margins

Gross margin is 23.12%, with operating margin of 11.77%, and net profit margin of -2.35%.
Gross Margin23.12%
Operating Margin11.77%
Pretax Margin3.53%
Net Profit Margin-2.35%
EBITDA Margin17.09%
EBIT Margin11.77%

Analyst Forecast

The average price target for Surgery Partners is $20.31, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$20.31
Price Target Upside59.42% Upside
Analyst ConsensusStrong Buy
Analyst Count9
Revenue Growth Forecast10.14%
EPS Growth Forecast-182.12%

Scores

Smart Score4
AI Score